Choosing Medications for ADHD: Q&A with Anne Buchanan, DO

ADHD medicationCCPR: Can you tell us about your current practice?

Dr. Buchanan: I am responsible for pediatric ER and floor consults, I supervise the school crisis walk-in clinic, and I am responsible for high-risk intakes in the clinic.

CCPR: We hear a lot about overdiagnosis of ADHD. What are your thoughts?

Dr. Buchanan: We all hear that the problem is that every child with bad behavior is given a stimulant. In actuality, the saddest cases are the children who have not been identified despite chronic academic underperformance and behavioral problems. By the time they get to middle school, they have anxiety and depression. They come to clinic for, say, suicidal ideation, and as we peel back the history, we find untreated ADHD. So, while overdiagnosis and overmedication is a huge problem, so is underdiagnosis. If children come in before they end up repeating first grade for the third time, then maybe we can change their paths. But there is, I think, a pretty significant minority of children who may not have as much of the disruptive behavior, and they kind of get just moved along—and in those cases, we really end up with a lot more problems down the line.

CCPR: So how do you do assessments?

Dr. Buchanan: We get history from the parent, from the child, and from the school. We have parents and teachers fill out rating scales, with another teacher form about the student’s strengths and weaknesses. Academic records, IEPs, special education plans, and previous testing are really helpful. If we have concerns about learning issues or developmental problems, we then refer for additional assessment.

CCPR: How do you sort out learning disabilities and ADHD?

Dr. Buchanan: Teachers may describe ADHD symptoms in certain settings, such as during testing or during certain subjects, or parents might not see symptoms at home. A child might also tell me that concentration is not the problem, but rather that the material is simply “too hard.” If I am suspicious of other psychiatric issues, we can do psychological testing. However, ADHD is often apparent with a proper history, collateral information, and observation of the child in the office.

CCPR: We hear from some pediatricians that they don’t think the kids they are referring to us actually have ADHD. Is this a common problem at that level of care?

Dr. Buchanan: Yes, and it is also something we sometimes see in our clinic. ADHD is a catchphrase that teachers and guidance counselors know, and they will often use it as a label as part of a referral. But larger issues are often evident during the initial consultation, things that the school may not know about. Many children we see have ADHD, but many do not.

CCPR: Does your evaluation change depending whether it’s a younger or older patient?

Dr. Buchanan: I find that younger children are often not as reliable as older kids in terms of self-reporting symptoms; however, we are still gathering the same records and the same information from parents and schools no matter the child’s age.

CCPR: We’ve also read that poor sleep can play a role with kids. Can you tell us more about that?

Dr. Buchanan: Lack of sleep/poor sleep hygiene is a huge factor in worsening existing ADHD symptoms and making any kid more inattentive during the day. Although getting kids to sleep is by no means a new issue, the overall increase in screen time over the years certainly has contributed to this, and we always ask and counsel about sleep.

CCPR: Moving on to treatment, what is your approach to choosing medications?

Dr. Buchanan: Most child psychiatrists, including myself, consider stimulants first-line. I view alpha-agonists as second-line, or sometimes I use them as augmenters to a stimulant, such as when we see only a partial response from a stimulant or when we are limited in dosing due to side effects. Agents such as Strattera (atomoxetine) and Wellbutrin (bupropion) are generally third-line. I deviate from that depending on contraindications or comorbidities, but most kids do well on stimulants. Ultimately, the recommendations that we land on depend on individual tolerability.

CCPR: Which medications do you tend to start with?

Dr. Buchanan: Keeping in mind that insurance formularies often dictate medication choices, especially when initiating treatment, it’s rare that I use newer formulations. I tend to start with a methylphenidate product, and I try a second one before going to an amphetamine product, because amphetamines can often be more potent, with more appetite suppression, irritability, and withdrawal symptoms. I generally start with any of the long-acting methylphenidate products—this would include medications such as Concerta, Metadate CD, Ritalin LA, and Focalin XR. For younger kids, I may consider starting with a short-acting, such as generic Ritalin (methylphenidate), as younger children may experience more side effects with stimulant medications and may not need as much coverage due to having fewer academic demands. The newer liquid, chewable, and dissolvable meds seem great for kids who struggle to swallow pills. However, insurance often doesn’t cover them initially. With some generics and Adderall XR, Metadate CD, Focalin XR, and Ritalin LA, it works well to snip the capsule and pour the beads into a spoonful of something with decent consistency—not a liquid—to ensure the child gets all the beads. Parents can use yogurt, oatmeal, or peanut butter, for example.

CCPR: What dose do you tend to shoot for?

Dr. Buchanan: I always start with the lowest dose, as some kids will respond to it. I will go up to and over the maximum recommended dose if needed, as long as we see improvement and as long as there are no side effects. For Metadate, the first dose is 10 mg, and if by 30 mg we have side effects and no improvement, I would switch to something else. Otherwise, I go to a maximum of 60 mg. For Concerta, I start at 18 mg. I’ve gone up to the max of 72 mg and even higher in certain patients, as long as the medicine is tolerated and the symptoms are improving.

CCPR: Are you typically going up by a pill a week?

Dr. Buchanan: In an ideal setting, I would raise the dose each week. In busier clinics, seeing kids that often is difficult, so frequently the dose gets raised every other week.

CCPR: So you won’t just tell parents to figure it out and come back in a month?

Dr. Buchanan: No, we don’t do that. Families need education. For us, it’s often a slow ramp up to get a parent to agree to medication. Private practice may be a different story because parents may come in already understanding the diagnosis, and if so, they might be more reliable in increasing the dose on their own and coming back in several weeks.

Choosing Medications for ADHD: Q&A with Anne Buchanan, DO

This article originally appeared in:

The Carlat Psychiatry Report
Click on the image to learn more or subscribe today!

This article was published in print September/October 2017 in Volume:Issue 8:6&7.

The Carlat Psychiatry Report

Carlat Publishing provides clear, authoritative, engaging, independent psychiatric education to make you look forward to learning, with the goal of helping you feel smarter, more competent, and more confident in your ability to help your patients become happy. We receive no corporate funding, which allows a clear-eyed evaluation of all available treatments. Learn more and subscribe to one of their newsletters here.


APA Reference
Psychiatry Report, T. (2019). Choosing Medications for ADHD: Q&A with Anne Buchanan, DO. Psych Central. Retrieved on September 19, 2020, from


Scientifically Reviewed
Last updated: 15 Apr 2019
Last reviewed: By John M. Grohol, Psy.D. on 15 Apr 2019
Published on All rights reserved.